- Filed
- Dec 12, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Dec 6, 2024 | 18.6M sh |
| Cash And Equivalents | Q3 2024 · Nov 2, 2024 | $87.01M |
| Cash And Equivalents | Q3 2024 · Feb 3, 2024 | $123.69M |
| Cash And Equivalents | Q3 2024 · Oct 28, 2023 | $380.7M |
| Cash And Equivalents | Q3 2024 · Jan 28, 2023 | $1.51B |
| Current Liabilities | Q3 2024 · Nov 2, 2024 | $896.27M |
| Current Liabilities | Q3 2024 · Feb 3, 2024 | $872.87M |
| Total Liabilities | Q3 2024 · Nov 2, 2024 | $4.65B |
| Total Liabilities | Q3 2024 · Feb 3, 2024 | $4.44B |
| Current Assets | Q3 2024 · Nov 2, 2024 | $1.28B |
| Current Assets | Q3 2024 · Feb 3, 2024 | $1.1B |
| Total Assets | Q3 2024 · Nov 2, 2024 | $4.46B |
| Total Assets | Q3 2024 · Feb 3, 2024 | $4.14B |
| Shares Diluted | Q3 2024 · Oct 28, 2023 | 18.37M sh |
| Shares Diluted | Q3 2024 · Oct 28, 2023 | 22.21M sh |
| Stock Repurchased | Q3 2024 · Oct 28, 2023 | $1.25B |
| Capex | Q3 2024 · Oct 28, 2023 | $131.84M |
| Operating Cash Flow | Q3 2024 · Oct 28, 2023 | $316.17M |
| Stockholders Equity | Q3 2024 · Oct 28, 2023 | −$333.21M |
| Stockholders Equity | Q3 2024 · Jul 29, 2023 | −$284.58M |
| Stockholders Equity | Q3 2024 · Jan 28, 2023 | $784.66M |
| Eps Diluted | Q3 2024 · Oct 28, 2023 | −$0.12 |
| Eps Diluted | Q3 2024 · Oct 28, 2023 | $5.23 |
| Eps Basic | Q3 2024 · Oct 28, 2023 | −$0.12 |
| Eps Basic | Q3 2024 · Oct 28, 2023 | $5.68 |
| Sga Expense | Q3 2024 · Oct 28, 2023 | $289.21M |
| Sga Expense | Q3 2024 · Oct 28, 2023 | $766.25M |
| Net Income | Q3 2024 · Oct 28, 2023 | −$2.19M |
| Net Income | Q3 2024 · Oct 28, 2023 | $116.18M |
| Operating Income | Q3 2024 · Oct 28, 2023 | $51.24M |
| Operating Income | Q3 2024 · Oct 28, 2023 | $301.82M |
| Gross Profit | Q3 2024 · Oct 28, 2023 | $340.45M |
| Gross Profit | Q3 2024 · Oct 28, 2023 | $1.07B |
| Cost Of Revenue | Q3 2024 · Oct 28, 2023 | $410.78M |
| Cost Of Revenue | Q3 2024 · Oct 28, 2023 | $1.22B |